6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Altamira Therapeutics Ltd.
Filed: October 4, 2023
Period of Report: October 4, 2023
Accession Number: 0001013762-23-001393

View Document ↗ View on SEC.gov ↗